In Part 2 of our conversation with Dr. Adam B. Murphy, we continue exploring the realities of Active Surveillance as a prostate cancer strategy. This follow-up episode dives deeper into the nuances of monitoring, patient lifestyle factors, and when a shift to active treatment may be necessary.

Dr. Murphy brings a wealth of expertise as an Associate Professor of Urology and Preventive Medicine at Northwestern Medicine. He continues to address key health disparities in prostate cancer, emphasizing the importance of tailored care for African American, Hispanic, and HIV-positive men, along with the role of biomarkers in disease progression.

This episode offers essential insight for men currently on or considering active surveillance, as well as for their families and caregivers. We break down myths, answer common concerns, and empower listeners to stay proactive and informed.

www.prostatecancerrealtalk.com